DoP forms five-member technical committee for Phase II PLI scheme
Dr Eswara Reddy, CDSCO; Dr Amol Kulkarni, NCL, Pune; Prof Arvind Bansal, NIPER Mohali; Satish Khanna, Fullife Healthcare and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Eswara Reddy
CDSCO to identify and set up two additional facilities for testing COVID-19 vaccines
The CDSCO has identified the challenges associated with COVID-19 vaccines are taking steps to mitigate them, informs Dr Eswara…
Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India
The Indian regulator has instructed Dr Reddy’s Laboratories carry out the trials of the vaccine with proper monitoring of immune…
Plans to revamp D&C Act 1940, launch Sugam portal Version II: Dr Eswara Reddy
The CDSCO is also making a list of government facilities for R&D and innovation and will be making it available on their…
Govt likely to announce short term incentive scheme, excipient makers may get benefit
DoP officials are formulating the guidelines
Govt may consider amendments in PLI scheme, submit recommendations: Dr Eswara Reddy
He asks associations to submit recommendations with scientific evidence for further discussion with the concerned authorities in…
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme
High-level panel to recommend reforms in India’s drug regulations
The panel, chaired by Rajesh Bhushan, the OSD to the Union Health Minister, comprises top drug and vaccine entrepreneurs as well…